SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
NCT06955260
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
410
Enrollment
OTHER
Sponsor class
Conditions
Congenital Heart Disease
Interventions
DRUG:
Empagliflozin 10 mg
OTHER:
Placebo
Sponsor
Subodh Verma
Collaborators
[object Object]
[object Object]